A New Way Forward
for Autoimmune Disease
Our Mission
Why We’re Here
We’re a biotechnology company with a big ambition: to transform the standard of care for autoimmune disease. By unlocking the innate power of natural killer (NK) cells — the immune system’s first responders — we’re working to eliminate malfunctioning B cells at the heart of some of medicine’s most devastating autoimmune conditions with the aim of alleviating suffering and delivering better health.
Patients First
Our Clinical Trial Promise
Instead of asking people with serious diseases to reconstruct their lives around our studies, drug developers should be striving to design our research around their lives. Read about what we’re doing to make clinical trial opportunities more accessible and equitable.
Nature
Boosted Killer Cells Show Promise For Autoimmune Disease
“Supercharged ‘natural killer’ cells could become a potent way to reset a disordered immune system,” according to one of the world's most prestigious scientific journals.
Our Autoimmune Targets
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of autoimmune diseases. Our proprietary technology is designed to harness the inherent disease-fighting capabilities of these immune cells to act against cells that are dysfunctional, diseased or otherwise abnormal.
Follow us on Linkedin
To mark #WorldSclerodermaDay, Nkarta is proud to share Vernita's story as the next installment of our ongoing #autoimmune patient storytelling series. Her journey brings forward the emotional realities of this disease in a way data alone cannot. We’re proud to present this warrior’s candid reflections on life with scleroderma. Her story reflects the personal experience of someone living with scleroderma. The views and experiences expressed are her own. Nkarta shares patient stories to raise awareness and does not provide medical advice or endorse any specific treatment or individual course of care. Individuals receive compensation from Nkarta for their participation. Individuals should consult qualified healthcare professionals for medical guidance.
